The FDA has approved Myqorzo for the treatment of adults with symptomatic oHCM to improve functional capacity and symptoms.
Winshear Gold Corp. (?Winshear' or the ?Company') reports that the Company has received final approval from the TSX Venture Exchange (the ?TSX-V') for the arms-length agreement with Peak Nickel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback